Install
Please login to see your bookmarks Register for free to our services and get the newsletter GTT Strategic Ventures, the investment fund of the GTT group, has completed a CHF 4.4 million funding round in novoMOF, a specialist in advanced materials for CO2 capture. This investment was made alongside Shift4Good, Regenerat
- 233articles · 365d
- 3+ day agolatest article
- Sep 16, 2025earliest in window
- 0%with images
- 273avg words
- Economy, Business & Finance 219
- Finance & Business 189
- Business & Industrial 139
- News 42
- Health & Wellness 23
- Medical 16
- Science & Nature 12
- Industrial 8
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Adaptyv raises $40M to build automated lab for agentic biology
2+ week, 3+ day ago (98+ words) The founders describe the endpoint as a biological gigafactory: enough automated experimental capacity for AI to learn from physical reality as quickly as it learns from text. 26.08.2026 13:58 Adaptyv raises $40M to build automated lab for agentic biology 19.09.2025 15:00 Adaptyv leaves the beta…...
Boehringer Ingelheim acquires equine health startup Evax
4+ week, 1+ day ago (164+ words) Boehringer Ingelheim has acquired Evax AG, a Swiss biotech company focused on therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic skin diseases. “We’re excited to have the potential to offer horse owners the…...
Biotech and more
4+ week, 1+ day ago (283+ words) Although biotech start-ups stand out with their mega-investments, there are numerous successful start-ups in the life sciences sector centred around pharmaceuticals. Vaderis Therapeutics, which focuses on developing targeted therapies for rare vascular diseases, has closed a USD 152 million series B…...
Oculis acquires development and commercial rights to Privosegtor
1+ mon, 1+ hour ago (276+ words) Biotech company Oculis will acquire all worldwide development and commercial rights to Privosegtor, one of its two core product candidates, from Accure. This acquisition will result in the termination of Oculis’ existing license agreement. The transaction consideration includes a $3.8 million…...
Cy Biopharma merges with Ensysce Biosciences
1+ mon, 2+ day ago (160+ words) Ensysce Biosciences, a clinical-stage company developing a new class of highly novel opioids for the treatment of severe pain, has acquired Zug-based Cy Biopharma, a clinical-stage biotechnology company focussed on novel neuroplastogenic therapies for severe chronic pain disorders. The acquisition…...
Three Swiss biotechs widen their reach into pharma, paediatrics and lung disease
1+ mon, 6+ day ago (224+ words) SOPHiA GENETICS, a Rolle (VD)-based genomics company founded in 2011, runs SOPHiA DDM, a cloud platform that analyses genomic and multimodal data for hospitals, laboratories and biopharma partners. The company reported second-quarter revenue of USD 23.3 million, up 27% year on year, and…...
Four Swiss medtechs mark commercial, regulatory and clinical milestones
1+ mon, 2+ week ago (210+ words) Arcoris bio has signed a distribution agreement to take its biomarker-detection kits into Europe and North America, Hi-D Imaging has secured expanded FDA clearance for its AI-driven heart-valve planning software and ABILITY Neurotech has carried out the first-in-human procedure for…...
CHF1.25 billion for Swiss start-ups – significant shifts across sectors and cantons
1+ mon, 4+ week ago (252+ words) Following a slight upturn in the first half of 2025, the total amount invested in the first six months of 2026 declined by 15.5% to CHF 1,245.03 million. It is thus at a similar level to that of previous years. The number of investments…...
Techbio company ALP Bio obtains CHF 150,000 from Venture Kick
2+ mon, 1+ week ago (292+ words) The biotech startup ALP Bio has obtained CHF 150,000 from Venture Kick to help drug developers identify immune-related risks earlier in the development process. By combining human immune tissue models with artificial intelligence, the company aims to improve the safety and…...
Biotech and Food companies strengthen management teams on the business side
2+ mon, 1+ week ago (184+ words) Several biotech companies hired Chief Business Officers, Chief Business Development Officers or Chief Commercial Officers. And Idorsia has a new CEO. New Chief Business officer for RhyGaze Incorporated in May 2024, RhyGaze is focused on developing gene therapies for retinal diseases…...